175 related articles for article (PubMed ID: 30146086)
1. [Adaptive designs for innovative therapies assessment: New methodological challenges].
Asselain B
Bull Cancer; 2018 Sep; 105(9):741-742. PubMed ID: 30146086
[No Abstract] [Full Text] [Related]
2. [Methodological approaches of clinical studies with targeted therapies].
Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine for managing diabetes.
Klonoff DC
J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409
[No Abstract] [Full Text] [Related]
4. Point: The Imprecise Pursuit of Precision Medicine: Are Biomarkers to Blame?
Gyawali B
J Natl Compr Canc Netw; 2017 Jul; 15(7):859-862. PubMed ID: 28687572
[No Abstract] [Full Text] [Related]
5. An overview of the design and conduct of the BATTLE trials.
Liu S; Lee JJ
Chin Clin Oncol; 2015 Sep; 4(3):33. PubMed ID: 26408300
[TBL] [Abstract][Full Text] [Related]
6. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
7. Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction.
Shah SJ
J Cardiovasc Transl Res; 2017 Jun; 10(3):322-336. PubMed ID: 28681133
[TBL] [Abstract][Full Text] [Related]
8. Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics.
Scher HI; Nasso SF; Rubin EH; Simon R
Clin Cancer Res; 2011 Nov; 17(21):6634-40. PubMed ID: 22046024
[TBL] [Abstract][Full Text] [Related]
9. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
Tsimberidou AM
Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine needs randomized clinical trials.
Saad ED; Paoletti X; Burzykowski T; Buyse M
Nat Rev Clin Oncol; 2017 May; 14(5):317-323. PubMed ID: 28169302
[TBL] [Abstract][Full Text] [Related]
11. Operationalizing Precision Cardiovascular Medicine: Three Innovations.
Wang JJ; Aboulhosn JA; Hofer IS; Mahajan A; Wang Y; Vondriska TM
Circ Res; 2016 Oct; 119(9):984-987. PubMed ID: 27737942
[TBL] [Abstract][Full Text] [Related]
12. Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies.
Lin JA; He P
Br Med Bull; 2015 Jun; 114(1):17-27. PubMed ID: 25921239
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.
Zardavas D; Piccart-Gebhart M
Am Soc Clin Oncol Educ Book; 2015; ():e183-90. PubMed ID: 25993171
[TBL] [Abstract][Full Text] [Related]
14. Genomic Alteration-Driven Clinical Trial Designs in Oncology.
Simon R
Ann Intern Med; 2016 Aug; 165(4):270-8. PubMed ID: 27214515
[TBL] [Abstract][Full Text] [Related]
15. [Dose finding methods for targeted agents: new perspectives].
Paoletti X; Postel-Vinay S; Servois V; Doussau A; Ollivier L; Le Tourneau C
Bull Cancer; 2010 Dec; 97(12):1485-95. PubMed ID: 21220226
[TBL] [Abstract][Full Text] [Related]
16. Master protocols in lung cancer: experience from Lung Master Protocol.
Lam VK; Papadimitrakopoulou V
Curr Opin Oncol; 2018 Mar; 30(2):92-97. PubMed ID: 29329112
[TBL] [Abstract][Full Text] [Related]
17. Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies.
Liu SV; Miller VA; Lobbezoo MW; Giaccone G
Eur J Cancer; 2014 Nov; 50(16):2747-51. PubMed ID: 25227487
[TBL] [Abstract][Full Text] [Related]
18. Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.
Antoniou M; Jorgensen AL; Kolamunnage-Dona R
PLoS One; 2016; 11(2):e0149803. PubMed ID: 26910238
[TBL] [Abstract][Full Text] [Related]
19. Measure for Measure: Biomarker standards and transparency.
FitzGerald GA
Sci Transl Med; 2016 Jun; 8(343):343fs10. PubMed ID: 27306662
[TBL] [Abstract][Full Text] [Related]
20. Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Eisenhauer EA; Seymour LK
Eur J Cancer; 2008 Jan; 44(1):25-9. PubMed ID: 17845846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
